CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
“We are honored to be recognized by such a prestigious and respected organization at the Neurotech Leaders Forum,” said Jon J. Snyder, President and CEO of Neuros Medical. “We feel fortunate to be part of an exclusive list of previous awardees and will use this award to continue to validate our past accomplishments and our future potential,” he added.
“Neuros represents a company that has created a strong focused market, and is executing the development of their technology in a sound and effective manner,” stated James Cavuoto, Editor and Publisher of Neurotech Reports. “Neuros holds strong promise for patients suffering from chronic amputation pain, as well as other potential applications. They are well deserving of this award and recognition,” said Cavuoto.
Neuros Medical is currently underway with a pilot clinical trial to evaluate the Company’s patented high frequency Electrical Nerve Block™ technology for use in acute treatment of pain in the residual limb of amputees. This study builds upon their successful first-in-man results in their initial study, in which 4 out of 5 patients reported over 50% pain reduction.
About Neuros Medical, Inc.
Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on developing proprietary therapies for unmet needs to patients worldwide. The Company’s patented platform technology, Electrical Nerve Block™, is focused on the elimination of chronic pain in a variety of applications including amputation pain, chronic post-surgical pain, chronic migraine, and trigeminal neuralgia.
Neurotech Reports, based in San Francisco, CA, is the publisher of the monthly newsletter, Neurotech Business Report, as well as market research reports in the neurotechnology industry.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50456626&lang=en